Navigation Links
MGT Chairman and CEO Buys 250,000 MGT shares
Date:10/8/2007

NEW YORK, Oct. 8 /PRNewswire-FirstCall/ -- MGT Capital Investments, Inc. (Amex: MGT), a holding company focused on the Healthcare Information Technology ("HCIT") sector, today announced that the Company's Chairman and CEO, Tim Paterson-Brown, has acquired 250,000 shares of MGT common stock from an existing shareholder in a single private transaction at $3.75 per share, for $937,500.

Tim Paterson-Brown, Chairman and CEO, stated, "It has been my belief for some time now that the value of MGT's current holdings in its subsidiaries is not accurately reflected in the current share price. Consequently, I have chosen to increase my personal investment in MGT over the past two years in an effort to take advantage of this valuation gap."

"In addition, I believe that our Medicsight subsidiary has tremendous potential for future growth. We recently announced the positive results of the ACRIN Study, endorsing the use of virtual colonoscopy, and we believe that as a result of this study, Medicsight's virtual colonoscopy technology will see increased future demand."

About MGT Capital Investments, Inc.

MGT Capital Investments, Inc is a holding company that focuses on investments in the global healthcare information technology market. We have two subsidiaries, Medicsight PLC and Medicexchange PLC. Medicsight PLC is a medical imaging software development company developing enterprise-wide Computer-Aided Detection (CAD) software which analyzes computer tomography (CT) scans for the early detection and measurement of colorectal polyps and lung lesions. Medicsight has focused on two of the leading causes of cancer- related death, colorectal cancer and lung cancer. Medicexchange PLC provides medical imaging professi
'/>"/>

SOURCE MGT Capital Investments, Inc.
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2

Related medicine news :

1. ViroPharma Shares Fall As FDA Moves Towards Generic Vancocin
2. Shares Of AVI BioPharma Drops On Reports Of Disappointing Early Drug Trail
3. Learn From a Leader: Smitherman shares a personal story about his battle with drugs
4. Sun Pharma Allots Shares Upon Fccbs Conversion
5. Zenotech Issues 20 Lakh Shares to Ranbaxy for Rs 20 Cr
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/22/2014)... -- Two sisters in high school have developed ways ... Medha Krishen use electronic stethoscopes, which electronically amplify body ... patterns or heartbeats. Ilina, a senior at Port ... a way to detect early lung damage in people ... Ilina recorded one breath cycle each from 16 smokers, ...
(Date:10/22/2014)... Salamon HealthDay Reporter TUESDAY, ... conventional in vitro fertilization (IVF) -- the incubation of embryos ... a device inside the vagina, new research suggests. Scientists ... called an INVOcell, might sharply cut costs for pricey IVF ... more accessible to those who don,t live near big-city assisted ...
(Date:10/22/2014)... Thompson HealthDay Reporter , MONDAY, ... Monday officially tightened guidelines for health workers treating Ebola patients, ... use of a respirator at all times. The U.S. ... tougher rules after two Dallas nurses contracted Ebola while caring ... Liberian national Thomas Eric Duncan. Nina Pham is currently being ...
(Date:10/20/2014)... (PRWEB) October 20, 2014 The newly ... must-have source of thousands of facts, figures and forecasts ... and 68 medical sector forecast categories the Worldwide ... global, regional and national views on the worldwide medical ... , The report gives you data for 2010-2019, covering ...
(Date:10/20/2014)... Allegheny General Hospital’s (AGH) Cardiovascular Institute ... to repair a damaged mitral valve as the heart ... developed by Abbott Vascular , is designed to ... condition in which the heart’s mitral valve leaflets fail ... the heart’s left ventricle into the left atrium. The ...
Breaking Medicine News(10 mins):Health News:Teen Sisters Develop Ways to Measure Lung, Heart Damage 2Health News:Experimental Infertility Treatment Seems Effective, Cheaper 2Health News:Experimental Infertility Treatment Seems Effective, Cheaper 3Health News:Experimental Infertility Treatment Seems Effective, Cheaper 4Health News:CDC Tightens Rules on Caring for Ebola Patients 2Health News:CDC Tightens Rules on Caring for Ebola Patients 3Health News:Worldwide Medical Market Forecasts to 2019 a New Research Report Added to ReportsnReports.com 2Health News:Worldwide Medical Market Forecasts to 2019 a New Research Report Added to ReportsnReports.com 3Health News:Worldwide Medical Market Forecasts to 2019 a New Research Report Added to ReportsnReports.com 4Health News:Allegheny General Hospital Introduces New, Beating-Heart Procedure for Mitral Valve Repair 2Health News:Allegheny General Hospital Introduces New, Beating-Heart Procedure for Mitral Valve Repair 3
... THURSDAY, Nov. 24 (HealthDay News) -- Higher doses of ... people suffering from aggressive lymphomas, such as diffuse large ... forms of non-Hodgkin,s lymphoma), according to new research. ... Lancet found this intensive form of chemotherapy, when ...
... , FRIDAY, Nov. 25 (HealthDay News) -- ... the mental health of black adults in the United ... 66 previous studies that included more than 18,000 black ... racism and trauma, including somatization (psychological distress that is ...
... , FRIDAY, Nov. 25 (HealthDay News) -- The sudden return ... cause some people to go into a funk, but an ... of the holidays year-round. "A large part of happiness ... holidays offer punctuated moments of joy we look forward to ...
... should be able to choose where they give birth, concludes ... first-time mums who opt for a home birth are at ... low in all birth settings. The researchers say their ... pregnancies a choice of birth setting" and will enable women ...
... Nov. 23 (HealthDay News) -- A 36-year-old husband and father ... (windpipe) has received the world,s first artificial trachea made with ... in The Lancet described the transplant surgery, which ... Stockholm, Sweden. Without the transplant, the authors of the ...
... HealthDay Reporter , WEDNESDAY, Nov. 23 (HealthDay News) ... enhanced quality of life may have hidden problems that could ... A letter to the editor in the Nov. 24 ... reports severe bleeding complications among trauma patients on the anti-clotting ...
Cached Medicine News:Health News:More Aggressive Chemo May Help Younger Lymphoma Patients: Study 2Health News:More Aggressive Chemo May Help Younger Lymphoma Patients: Study 3Health News:How to Extend Holiday Cheer 2Health News:Pregnant women at low risk of complications can safely be offered a choice of where to give birth 2Health News:1st Artificial Windpipe Made With Stem Cells Seems Successful 2Health News:Newer Blood Thinner May Pose Danger to Trauma Patients 2Health News:Newer Blood Thinner May Pose Danger to Trauma Patients 3
(Date:10/22/2014)...  Early symptoms of diabetic eye and vision ... technology, coupled with yearly, comprehensive eye exams, are ... of eye diseases, including those associated with diabetes, ... untreated, these diseases can potentially lead to vision ... optometric researchers have deployed a new tool that ...
(Date:10/22/2014)... -- InVivo Therapeutics Holdings Corp. (OTCQB: NVIV) based in ... cord injury (SCI) treatment with their novel Neuro-Spinal Scaffold. ... regrowth in the spinal cord area when cells are ... polymer, the scaffold ultimately breaks down to water and ... NVIV has recently attracted significant investor attention with the ...
(Date:10/22/2014)... YORK , Oct. 22, 2014 Provectus ... dermatology therapies. PV-10, its novel investigational drug for cancer, ... potential for systemic side effects. Its oncology focus is ... Provectus has completed phase 2 trials of PV-10 as ... a topical treatment for atopic dermatitis and psoriasis. ...
Breaking Medicine Technology:Technology Advancements Enhance Early Detection of Eye Diseases Associated with Diabetes 2Technology Advancements Enhance Early Detection of Eye Diseases Associated with Diabetes 3InVivo Therapeutics Analyst Coverage Initiated: Analyst Report by BrokerBank Securities, Inc. 2InVivo Therapeutics Analyst Coverage Initiated: Analyst Report by BrokerBank Securities, Inc. 3Provectus Biopharmaceuticals Looks at the Asian Markets: Analyst Coverage by Small Cap Traders 2
... Inc., the largest,privately held spinal implant manufacturer in ... Spacers have been implanted under an,Investigational Device Exemption ... II and Dr. Rhett Murray., The FLEXUS(TM) ... two,spinous processes with minimal disruption to the surrounding ...
... (BiTE) showing clinical benefit in cancer,patients; Blinatumomab enables patients own T ... ... cancer cells, BETHESDA, Md., Aug. 14 Micromet, Inc.,(Nasdaq: ... treatment of cancer, inflammation and autoimmune,diseases, today announced publication of a ...
Cached Medicine Technology:First FLEXUS(TM) Interspinous Spacer Surgeries for IDE Clinical Trial 2Clinical Data Published in 'Science' Show Tumor Regressions in Relapsed Lymphoma Patients Treated with T Cell Engaging BiTE Antibody Blinatumomab 2Clinical Data Published in 'Science' Show Tumor Regressions in Relapsed Lymphoma Patients Treated with T Cell Engaging BiTE Antibody Blinatumomab 3Clinical Data Published in 'Science' Show Tumor Regressions in Relapsed Lymphoma Patients Treated with T Cell Engaging BiTE Antibody Blinatumomab 4Clinical Data Published in 'Science' Show Tumor Regressions in Relapsed Lymphoma Patients Treated with T Cell Engaging BiTE Antibody Blinatumomab 5Clinical Data Published in 'Science' Show Tumor Regressions in Relapsed Lymphoma Patients Treated with T Cell Engaging BiTE Antibody Blinatumomab 6
Double-ended. Sharp and blunt 6.5 mm tips. Designated most popular model or size....
Octagonal handle. 3 mm wide....
Desmarres Retractor Size 4...
2.0 mm cup , straight shaft, Flat handle, length 125.0 mm....
Medicine Products: